Page last updated: 2024-11-07

s 20928

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID127856
CHEMBL ID12296
SCHEMBL ID6254856
MeSH IDM0278305

Synonyms (24)

Synonym
gtpl1360
s20928 ,
L000529
CHEMBL12296 ,
n-(2-naphthalen-1-ylethyl)cyclobutanecarboxamide
152302-33-5
s 20928
s-20928
n-(2-(1-naphthalenyl)ethyl)cyclobutanecarboxamide
cyclobutanecarboxamide, n-(2-(1-naphthalenyl)ethyl)-
pux4nyc22l ,
unii-pux4nyc22l
cyclobutanecarboxamide,n-[2-(1-naphthalenyl)ethyl]-
GLXSBZGTGMPDKH-UHFFFAOYSA-N
n-[2-(1-naphthyl)ethyl]cyclobutanecarboxamide
Z384527568
SCHEMBL6254856
DTXSID00164994
bdbm50472535
n-[2-naphth-1-yl-ethyl]-cyclobutyl carboxamide
AKOS030612657
Q27088664
EN300-18418908
n-[2-(naphthalen-1-yl)ethyl]cyclobutanecarboxamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Melatonin receptor type 1AGallus gallus (chicken)Ki0.78700.00000.16870.8700AID107397
Melatonin receptor type 1CGallus gallus (chicken)Ki0.78700.00000.16870.8700AID107397
Melatonin receptor type 1BGallus gallus (chicken)Ki0.78700.00000.16170.8700AID107397
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Melatonin receptor type 1AGallus gallus (chicken)EC50 (µMol)1.00000.01010.01640.0226AID107396
Melatonin receptor type 1CGallus gallus (chicken)EC50 (µMol)1.00000.01010.01640.0226AID107396
Melatonin receptor type 1BGallus gallus (chicken)EC50 (µMol)1.00000.01010.01640.0226AID107396
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (4)

Processvia Protein(s)Taxonomy
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathwayMelatonin receptor type 1AGallus gallus (chicken)
negative regulation of glycolytic processMelatonin receptor type 1AGallus gallus (chicken)
negative regulation of glucose importMelatonin receptor type 1AGallus gallus (chicken)
G protein-coupled receptor signaling pathwayMelatonin receptor type 1AGallus gallus (chicken)
negative regulation of glycolytic processMelatonin receptor type 1CGallus gallus (chicken)
negative regulation of glucose importMelatonin receptor type 1CGallus gallus (chicken)
G protein-coupled receptor signaling pathwayMelatonin receptor type 1CGallus gallus (chicken)
G protein-coupled receptor signaling pathwayMelatonin receptor type 1BGallus gallus (chicken)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (4)

Processvia Protein(s)Taxonomy
melatonin receptor activityMelatonin receptor type 1AGallus gallus (chicken)
hormone bindingMelatonin receptor type 1AGallus gallus (chicken)
melatonin bindingMelatonin receptor type 1AGallus gallus (chicken)
G protein-coupled receptor activityMelatonin receptor type 1AGallus gallus (chicken)
melatonin receptor activityMelatonin receptor type 1CGallus gallus (chicken)
melatonin bindingMelatonin receptor type 1CGallus gallus (chicken)
G protein-coupled receptor activityMelatonin receptor type 1CGallus gallus (chicken)
melatonin receptor activityMelatonin receptor type 1BGallus gallus (chicken)
G protein-coupled receptor activityMelatonin receptor type 1BGallus gallus (chicken)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
receptor complexMelatonin receptor type 1AGallus gallus (chicken)
plasma membraneMelatonin receptor type 1AGallus gallus (chicken)
nucleoplasmMelatonin receptor type 1CGallus gallus (chicken)
plasma membraneMelatonin receptor type 1CGallus gallus (chicken)
plasma membraneMelatonin receptor type 1BGallus gallus (chicken)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1346274Human MT2 receptor (Melatonin receptors)2003Naunyn-Schmiedeberg's archives of pharmacology, Jun, Volume: 367, Issue:6
New selective ligands of human cloned melatonin MT1 and MT2 receptors.
AID1346220Human MT1 receptor (Melatonin receptors)2003Naunyn-Schmiedeberg's archives of pharmacology, Jun, Volume: 367, Issue:6
New selective ligands of human cloned melatonin MT1 and MT2 receptors.
AID107397Inhibition of 2-[125I]- iodomelatonin from chicken brain melatonin receptors1999Journal of medicinal chemistry, Mar-25, Volume: 42, Issue:6
Melatonergic properties of the (+)- and (-)-enantiomers of N-(4-methoxy-2,3-dihydro-1H-phenalen-2-yl)amide derivatives.
AID107396Functional activity against melatonin receptor in lightening Xenopus laevis tadpole skin1999Journal of medicinal chemistry, Mar-25, Volume: 42, Issue:6
Melatonergic properties of the (+)- and (-)-enantiomers of N-(4-methoxy-2,3-dihydro-1H-phenalen-2-yl)amide derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's8 (47.06)18.2507
2000's9 (52.94)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.40 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]